What they were paid
Starling Oncology Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $75,000 | $125,000 | $0 | $0 | $200,000 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Starling Oncology, Inc. DEF 14A filed April 30, 2026, accession 0001193125-26-197350, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Starling Oncology pays directors a $75,000 cash retainer and $125,000 in RSUs.
The rest of the Starling Oncology board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Anne McGeorge | Chair of the Board | $424,998 |
| Brad Hively | Independent Director | $315,000 |
| Daniel Virnich | Director | $0 |
| Karen Johnson | Independent Director | $350,001 |
| Kimberly Tzoumakas | Independent Director | — |
| Mark Pacala | Independent Director | $340,000 |
| Mark Stolper | Independent Director | — |
| Mohit Kaushal | Independent Director | $369,999 |
The full Starling Oncology compensation record
free company briefThis page is one director within Starling Oncology's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat